RT Journal Article
SR Electronic
T1 Shared genetic etiology between cortical brain morphology and tobacco, alcohol, and cannabis use
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.28.21254282
DO 10.1101/2021.03.28.21254282
A1 Jill A. Rabinowitz
A1 Adrian I. Campos
A1 Jue-Sheng Ong
A1 Luis M. García-Marín
A1 Sarael Alcauter
A1 Brittany L. Mitchell
A1 Katrina S. Grasby
A1 Gabriel Cuéllar-Partida
A1 Nathan A. Gillespie
A1 Andrew S. Huhn
A1 Nicholas G. Martin
A1 Paul M. Thompson
A1 Sarah E. Medland
A1 Brion S. Maher
A1 Miguel E. Rentería
YR 2021
UL http://medrxiv.org/content/early/2021/04/04/2021.03.28.21254282.abstract
AB Genome-wide association studies (GWAS) have independently identified hundreds of genomic regions associated with brain morphology and substance use. However, the genetic overlap between brain structure and substance use has not been characterized. Here we leverage GWAS summary data of 71 brain imaging measures and alcohol, tobacco, and cannabis use to investigate their genetic overlap using LD score regression. We also used genomic structural equation modeling to model a ‘substance use common genetic factor’ and examined its genetic overlap with brain structure. After accounting for multiple testing, we identified eight significant negative genetic correlations, including between alcoholic drinks per week and average cortical thickness and intracranial volume with the age of smoking initiation; and five positive genetic correlations, including between insula surface area and lifetime cannabis use, and between the common factor with pericalcarine surface area. Our findings highlight a shared genetic etiology between variation in cortical brain morphology and substance use.Competing Interest StatementThe authors have declared no competing interest.Funding StatementA.I.C. and L.M.G.-M. are supported by UQ Research Training Scholarships from The University of Queensland (UQ). B.L.M. is supported through a Queensland University of Technology (QUT) Postgraduate Research Scholarship. P.M.T. was supported in part by NIH grant U54 EB020403. M.E.R. thanks support of the Australian National Health and Medical Research Council and Australian Research Council (ARC) through a Research Fellowship (GNT1102821).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This project was approved by the QIMR Berghofer Human Research Ethics Committee. In addition, for datasets that are not openly public and require an application (ENIGMA and 23andMe), approval was sought form to use their summary data in this specific study. Regarding data derived from the ENIGMA consortium, as indicated in the original article, all participants were genotyped individuals, with cortical MRI data, from 60 worldwide cohorts. Participants in all cohorts gave written informed consent, and each site obtained approval from local research ethics committees or institutional review boards. Ethics approval for the meta-analysis was granted by the QIMR Berghofer Medical Research Institute Human Research Ethics Committee. Summary data were accessed through direct application to the ENIGMA consortium via its website. Research participants in the original Alcohol, Tobacco, and Cannabis GWAS provided informed consent to take part in this research under a protocol approved by the AAHRPP-accredited institutional review board, Ethical and Independent Review Services. Summary data were accessed through direct application to 23andMe, with an MTA and Statement of Work between QIMR Berghofer and 23andMe for this project.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available upon request from ENIGMA and 23andMe. Data from ICC and GSCAN are publicly available. http://enigma.ini.usc.edu/ https://research.23andme.com/dataset-access/ https://ibg.colorado.edu/mediawiki/index.php/GSCAN https://www.ru.nl/bsi/research/group-pages/substance-use-addiction-food-saf/vm-saf/genetics/international-cannabis-consortium-icc/